Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Doxazosin mesilate |
Is a |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing doxazosin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Doxazosin 4mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Doxazosin 8mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Doxazosin adverse reaction |
Causative agent (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Doxazosin allergy |
Causative agent (attribute) |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely doxazosin 8 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Doxazosin allergy |
Causative agent (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely doxazosin (as doxazosin mesilate) 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Doxazosin (as doxazosin mesilate) 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely doxazosin (as doxazosin mesilate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely doxazosin 8 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely doxazosin 8 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Doxazosin mesilate |
Is modification of (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely doxazosin (as doxazosin mesilate) 8 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Doxazosin (as doxazosin mesylate) 4 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing doxazosin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely doxazosin 8 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only doxazosin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only doxazosin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Doxazosin (as doxazosin mesilate) 8 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Doxazosin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |